Digital Endpoints Are Coming — and Payers Need to Be Ready
-
Jul 14, 2022
Digital evidence from apps, wearables and remote sensors is already being used by medical product developers to test and measure their effectiveness. The FDA issued draft guidance earlier this year on the use of digital health technologies to acquire data remotely from clinical trial participants. And the European Medicines Agency approved its first digital endpoint, accepting one to be used to evaluate medications for Duchenne Muscular Dystrophy.
Payers are next, warned Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe), speaking at the AHIP 2022 conference in Las Vegas, N.V.
Read more© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.